Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
5(33%)
Results Posted
63%(5 trials)

Phase Distribution

Ph phase_2
9
60%
Ph phase_3
2
13%
Ph phase_1
2
13%

Phase Distribution

2

Early Stage

9

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
9(69.2%)
Phase 3Large-scale testing
2(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(8)
Other(2)

Detailed Status

Completed8
Recruiting3
Active, not recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
15
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (15.4%)
Phase 29 (69.2%)
Phase 32 (15.4%)

Trials by Status

recruiting320%
completed853%
active_not_recruiting213%
unknown213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT06192160Phase 2

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Recruiting
NCT05586230Phase 1

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

Recruiting
NCT06441006Phase 2

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Recruiting
NCT00042289

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Completed
NCT05686356Phase 2

A Pan-TB Regimen Targeting Host and Microbe

Active Not Recruiting
NCT06058299Phase 2

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Active Not Recruiting
NCT04179500Phase 2

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Completed
NCT04309656Phase 1

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Completed
NCT03942354

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Completed
NCT02589782Phase 2

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Completed
NCT04207112Phase 2

Economic Evaluation of New MDR TB Regimens

Completed
NCT03338621Phase 2

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Completed
NCT05040126Phase 3

Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India

Unknown
NCT03086486Phase 3

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Completed
NCT04081077Phase 2

PRACTECAL-PKPD Sub Study

Unknown

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15